Log in to save to my catalogue

Disulfidptosis in pediatric AML: a multi-omics approach to risk stratification and potential therape...

Disulfidptosis in pediatric AML: a multi-omics approach to risk stratification and potential therape...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_12131395

Disulfidptosis in pediatric AML: a multi-omics approach to risk stratification and potential therapeutic strategy

About this item

Full title

Disulfidptosis in pediatric AML: a multi-omics approach to risk stratification and potential therapeutic strategy

Publisher

England: BioMed Central

Journal title

Cancer cell international, 2025-06, Vol.25 (1), p.199

Language

English

Formats

Publication information

Publisher

England: BioMed Central

More information

Scope and Contents

Contents

The evolving molecular portrait of acute myeloid leukemia (AML) has exposed previously unrecognized cell death programs that fuel disease progression and treatment resistance-uncovering untapped therapeutic potential. Recent work has uncovered disulfidptosis-a novel form of programmed cell death (PDC) triggered by glucose deprivation in SLC7A11-hig...

Alternative Titles

Full title

Disulfidptosis in pediatric AML: a multi-omics approach to risk stratification and potential therapeutic strategy

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_12131395

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_12131395

Other Identifiers

ISSN

1475-2867

E-ISSN

1475-2867

DOI

10.1186/s12935-025-03824-9

How to access this item